{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:24Z","timestamp":1791389544505,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Infectious diseases are among the leading causes of death in many low-income countries, such as Ethiopia. Without reliable local data concerning causative pathogens and antimicrobial resistance, empiric treatment is suboptimal. The objective of this study was to characterize gram-negative bacteria (GNB) as pathogens and their resistance pattern in hospitalized patients with infections in central Ethiopia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients \u2265\u20091\u00a0year of age with fever admitted to the Asella Referral and Teaching Hospital from April 2016 to June 2018 were included. Blood and other appropriate clinical specimens were collected and cultured on appropriate media. Antibiotic susceptibility testing (AST) was performed using the Kirby\u2013Bauer method and VITEK\u00ae 2. Species identification and detection of resistance genes were conducted using MALDI-ToF MS (VITEK\u00ae MS) and PCR, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 684 study participants, 54.2% were male, and the median age was 22.0 (IQR: 14\u201335) years. Blood cultures were positive in 5.4% (n\u2009=\u200937) of cases. Among other clinical samples, 60.6% (20\/33), 20.8% (5\/24), and 37.5% (3\/8) of swabs\/pus, urine and other body fluid cultures, respectively, were positive. Among 66 pathogenic isolates, 57.6% (n\u2009=\u200938) were GNB, 39.4% (n\u2009=\u200926) were gram-positive, and 3.0% (n\u2009=\u20092) were <jats:italic>Candida<\/jats:italic> species. Among the isolated GNB, 42.1% (16\/38) were <jats:italic>Escherichia coli<\/jats:italic>, 23.7% (9\/38) <jats:italic>Klebsiella pneumoniae<\/jats:italic> and 10.5% (4\/38) <jats:italic>Pseudomonas aeruginosa<\/jats:italic>.<\/jats:p>\n                <jats:p>In total, 27\/38\u00a0gram-negative isolates were available for further analysis. Resistance rates were as follows: ampicillin\/sulbactam, 92.6% (n\u2009=\u200925); cefotaxime, 88.9% (n\u2009=\u200924); ceftazidime, 74.1% (n\u2009=\u200920); cefepime, 74.1% (n\u2009=\u200920); gentamicin, 55.6% (n\u2009=\u200915); piperacillin\/tazobactam, 48.1% (n\u2009=\u200913); meropenem, 7.4% (n\u2009=\u20092); and amikacin, 3.7% (n\u2009=\u20091). The <jats:italic>bla<\/jats:italic><jats:sub>NDM-1<\/jats:sub> gene was detected in one <jats:italic>K. pneumoniae<\/jats:italic> and one <jats:italic>Acinetobacter baumannii<\/jats:italic> isolate, which carried an additional <jats:italic>bla<\/jats:italic><jats:sub>OXA-51<\/jats:sub> gene. The ESBL enzymes were detected in 81.5% (n\u2009=\u200922) of isolates as follows: TEM, 77.2% (n\u2009=\u200917); CTX-M-1 group, 68.2% (n\u2009=\u200915); SHV group, 27.3% (n\u2009=\u20096); and CTX-M-9 group, 9.1% (n\u2009=\u20092). Based on the in vitro antimicrobial susceptibility results, empiric treatment initiated in 13 of 18 (72.2%) patients was likely ineffective.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We report a high prevalence of ESBL-producing bacteria (81.5%) and carbapenem resistance (7.4%), with more than half of GNB carrying two or more ESBL enzymes resulting in suboptimal empiric antibiotic therapy. These findings indicate a need for local and national antimicrobial resistance surveillance and the strengthening of antimicrobial stewardship programs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01053-7","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T21:20:02Z","timestamp":1642281602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prevalence and characterization of antimicrobial resistance among gram-negative bacteria isolated from febrile hospitalized patients in central Ethiopia"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9505-9341","authenticated-orcid":false,"given":"Tafese Beyene","family":"Tufa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Martin","family":"Orth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Wienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sileshi","family":"Abdissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewdu","family":"Hurissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Sch\u00f6nfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bosselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"H\u00e4ussinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Feldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"1053_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12963-017-0145-1","volume":"15","author":"A Misganaw","year":"2017","unstructured":"Misganaw A, Haregu TN, Deribe K, Tessema GA, Deribew A, Melaku YA, Amare AT, Abera SF, Gedefaw M, Dessalegn M, Lakew Y, Bekele T, Mohammed M, Yirsaw BD, Damtew SA, Krohn KJ, Achoki T, Blore J, Assefa Y, Naghavi M. National mortality burden due to communicable, non-communicable, and other diseases in Ethiopia, 1990\u20132015: findings from the Global Burden of Disease Study 2015. Popul Health Metr. 2017;15:29.","journal-title":"Popul Health Metr"},{"key":"1053_CR2","doi-asserted-by":"crossref","unstructured":"Alosaimy S, Jorgensen SCJ, Lagnf AM, Melvin S, Mynatt RP, Carlson TJ, Garey KW, Allen D, Venugopalan V, Veve M, Athans V, Saw S, Yost CN, Davis SL, Rybak MJ. 2020. Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative bacterial infections. Open Forum Infect Dis 7:ofaa051.","DOI":"10.1093\/ofid\/ofaa051"},{"key":"1053_CR3","unstructured":"CDC. 2019. Antibiotic resistance threats in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2019 wwwcdcgov\/DrugResistance\/Biggest-Threatshtml."},{"key":"1053_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13613-015-0061-0","volume":"5","author":"\u00c9 Rupp\u00e9","year":"2015","unstructured":"Rupp\u00e9 \u00c9, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5:61.","journal-title":"Ann Intensive Care"},{"key":"1053_CR5","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/jac\/dkx146","volume":"72","author":"ER Bevan","year":"2017","unstructured":"Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M \u03b2-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72:2145\u201355.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 4","key":"1053_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0213-005X(14)70168-5","volume":"32","author":"L Mart\u00ednez-Mart\u00ednez","year":"2014","unstructured":"Mart\u00ednez-Mart\u00ednez L, Gonz\u00e1lez-L\u00f3pez JJ. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology. Enferm Infecc Microbiol Clin. 2014;32(Suppl 4):4\u20139.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"1053_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jac\/dkz464","volume":"75","author":"R Lester","year":"2020","unstructured":"Lester R, Musicha P, van Ginneken N, Dramowski A, Hamer DH, Garner P, Feasey NA. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review. J Antimicrob Chemother. 2020;75:492\u2013507.","journal-title":"J Antimicrob Chemother"},{"key":"1053_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4065\/mcp.2010.0639","volume":"86","author":"S Leekha","year":"2011","unstructured":"Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011;86:156\u201367.","journal-title":"Mayo Clin Proc"},{"key":"1053_CR9","doi-asserted-by":"crossref","unstructured":"Fuchs A, Tufa TB, H\u00f6rner J, Hurissa Z, Nordmann T, Bosselmann M, Abdissa S, Sorsa A, Orth HM, Jensen BO, MacKenzie C, Pfeffer K, Kaasch AJ, Bode JG, H\u00e4ussinger D, Feldt T. 2021. Clinical and microbiological characterization of sepsis and evaluation of sepsis scores. PLoS One 16:e0247646.","DOI":"10.1371\/journal.pone.0247646"},{"key":"1053_CR10","doi-asserted-by":"crossref","unstructured":"Moges F, Eshetie S, Abebe W, Mekonnen F, Dagnew M, Endale A, Amare A, Feleke T, Gizachew M, Tiruneh M. 2019. High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region. PLoS One 14:e0215177.","DOI":"10.1371\/journal.pone.0215177"},{"key":"1053_CR11","doi-asserted-by":"crossref","unstructured":"Beyene D, Bitew A, Fantew S, Mihret A, Evans M. 2019. Multidrug-resistant profile and prevalence of extended spectrum \u03b2-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One 14:e0222911.","DOI":"10.1371\/journal.pone.0222911"},{"key":"1053_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/jac\/dku450","volume":"70","author":"LM Strau\u00df","year":"2015","unstructured":"Strau\u00df LM, Dahms C, Becker K, Kramer A, Kaase M, Mellmann A. Development and evaluation of a novel universal \u03b2-lactamase gene subtyping assay for blaSHV, blaTEM and blaCTX-M using clinical and livestock-associated Escherichia coli. J Antimicrob Chemother. 2015;70:710\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"1053_CR13","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1128\/AAC.00118-13","volume":"57","author":"AF Wendel","year":"2013","unstructured":"Wendel AF, Brodner AH, Wydra S, Ressina S, Henrich B, Pfeffer K, Toleman MA, Mackenzie CR. Genetic characterization and emergence of the metallo-\u03b2-lactamase GIM-1 in Pseudomonas spp. and Enterobacteriaceae during a long-term outbreak. Antimicrob Agents Chemother. 2013;57:5162\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1053_CR14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1099\/jmm.0.045823-0","volume":"61","author":"XZ Huang","year":"2012","unstructured":"Huang XZ, Cash DM, Chahine MA, Nikolich MP, Craft DW. Development and validation of a multiplex TaqMan real-time PCR for rapid detection of genes encoding four types of class D carbapenemase in Acinetobacter baumannii. J Med Microbiol. 2012;61:1532\u20137.","journal-title":"J Med Microbiol"},{"key":"1053_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s13104-019-4520-9","volume":"12","author":"M Lubwama","year":"2019","unstructured":"Lubwama M, Phipps W, Najjuka CF, Kajumbula H, Ddungu H, Kambugu JB, Bwanga F. Bacteremia in febrile cancer patients in Uganda. BMC Res Notes. 2019;12:464.","journal-title":"BMC Res Notes"},{"key":"1053_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s40064-015-1056-x","volume":"4","author":"AG Wasihun","year":"2015","unstructured":"Wasihun AG, Wlekidan LN, Gebremariam SA, Dejene TA, Welderufael AL, Haile TD, Muthupandian S. Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among febrile patients in Mekelle Hospital. Northern Ethiopia Springerplus. 2015;4:314.","journal-title":"Northern Ethiopia Springerplus"},{"key":"1053_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12941-021-00422-1","volume":"20","author":"F Moges","year":"2021","unstructured":"Moges F, Gizachew M, Dagnew M, Amare A, Sharew B, Eshetie S, Abebe W, Million Y, Feleke T, Tiruneh M. Multidrug resistance and extended-spectrum beta-lactamase producing Gram-negative bacteria from three Referral Hospitals of Amhara region. Ethiopia Ann Clin Microbiol Antimicrob. 2021;20:16.","journal-title":"Ethiopia Ann Clin Microbiol Antimicrob"},{"key":"1053_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12879-015-1127-1","volume":"15","author":"TH Boyles","year":"2015","unstructured":"Boyles TH, Davis K, Crede T, Malan J, Mendelson M, Lesosky M. Blood cultures taken from patients attending emergency departments in South Africa are an important antibiotic stewardship tool, which directly influences patient management. BMC Infect Dis. 2015;15:410.","journal-title":"BMC Infect Dis"},{"key":"1053_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13054-018-2183-x","volume":"22","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Russo A, Righi E, Dolso E, Merelli M, Cannarsa N, D\u2019Aurizio F, Sartor A, Curcio F. Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients. Crit Care. 2018;22:252.","journal-title":"Crit Care"},{"key":"1053_CR20","doi-asserted-by":"crossref","unstructured":"Polilli E, Sozio F, Frattari A, Persichitti L, Sensi M, Posata R, Di Gregorio M, Sciacca A, Flacco ME, Manzoli L, Di Iorio G, Parruti G. 2020. Comparison of Monocyte Distribution Width (MDW) and Procalcitonin for early recognition of sepsis. PLoS One 15:e0227300.","DOI":"10.1371\/journal.pone.0227300"},{"key":"1053_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.chest.2017.05.039","volume":"152","author":"ED Crouser","year":"2017","unstructured":"Crouser ED, Parrillo JE, Seymour C, Angus DC, Bicking K, Tejidor L, Magari R, Careaga D, Williams J, Closser DR, Samoszuk M, Herren L, Robart E, Chaves F. Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker. Chest. 2017;152:518\u201326.","journal-title":"Chest"},{"key":"1053_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13756-019-0488-4","volume":"8","author":"DS Teklu","year":"2019","unstructured":"Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa. Ethiopia Antimicrob Resist Infect Control. 2019;8:39.","journal-title":"Ethiopia Antimicrob Resist Infect Control"},{"key":"1053_CR23","doi-asserted-by":"publisher","first-page":"4846159","DOI":"10.1155\/2018\/4846159","volume":"2018","author":"M Abayneh","year":"2018","unstructured":"Abayneh M, Tesfaw G, Abdissa A. Isolation of extended-spectrum \u03b2-lactamase- (ESBL-) producing Escherichia coli and Klebsiella pneumoniae from patients with community-onset urinary tract infections in Jimma University Specialized Hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol. 2018;2018:4846159.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"1053_CR24","first-page":"511","volume":"14","author":"M Kettner","year":"1988","unstructured":"Kettner M, Kr\u0107m\u00e9ry V. Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usage. Drugs Exp Clin Res. 1988;14:511\u20137.","journal-title":"Drugs Exp Clin Res"},{"key":"1053_CR25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2147\/TCRM.S210872","volume":"15","author":"R Wang","year":"2019","unstructured":"Wang R, Yang Q, Zhang S, Hong Y, Zhang M, Jiang S. Trends and correlation of antibiotic susceptibility and antibiotic consumption at a large teaching hospital in China (2007\u20132016): a surveillance study. Ther Clin Risk Manag. 2019;15:1019\u201327.","journal-title":"Ther Clin Risk Manag"},{"key":"1053_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijmm.2013.02.008","volume":"303","author":"MM D'Andrea","year":"2013","unstructured":"D\u2019Andrea MM, Arena F, Pallecchi L, Rossolini GM. CTX-M-type \u03b2-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol. 2013;303:305\u201317.","journal-title":"Int J Med Microbiol"},{"key":"1053_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ja.2015.68","volume":"68","author":"JO Ogutu","year":"2015","unstructured":"Ogutu JO, Zhang Q, Huang Y, Yan H, Su L, Gao B, Zhang W, Zhao J, Cai W, Li W, Zhao H, Chen Y, Song W, Chen X, Fu Y, Zhang F. Development of a multiplex PCR system and its application in detection of blaSHV, blaTEM, blaCTX-M-1, blaCTX-M-9 and blaOXA-1 group genes in clinical Klebsiella pneumoniae and Escherichia coli strains. J Antibiot (Tokyo). 2015;68:725\u201333.","journal-title":"J Antibiot (Tokyo)"},{"key":"1053_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12879-017-2289-9","volume":"17","author":"M Pritsch","year":"2017","unstructured":"Pritsch M, Zeynudin A, Messerer M, Baumer S, Liegl G, Schubert S, L\u00f6scher T, Hoelscher M, Belachew T, Rachow A, Wieser A. First report on bla (NDM-1)-producing Acinetobacter baumannii in three clinical isolates from Ethiopia. BMC Infect Dis. 2017;17:180.","journal-title":"BMC Infect Dis"},{"key":"1053_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1186\/s13104-018-3738-2","volume":"11","author":"K Ssekatawa","year":"2018","unstructured":"Ssekatawa K, Byarugaba DK, Wampande E, Ejobi F. A systematic review: the current status of carbapenem resistance in East Africa. BMC Res Notes. 2018;11:629.","journal-title":"BMC Res Notes"},{"key":"1053_CR30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1089\/mdr.2016.0003","volume":"23","author":"MAF Khalil","year":"2017","unstructured":"Khalil MAF, Elgaml A, El-Mowafy M. Emergence of multidrug-resistant New Delhi metallo-\u03b2-lactamase-1-producing Klebsiella pneumoniae in Egypt. Microb Drug Resist. 2017;23:480\u20137.","journal-title":"Microb Drug Resist"},{"key":"1053_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12879-018-3581-z","volume":"18","author":"MA Adam","year":"2018","unstructured":"Adam MA, Elhag WI. Prevalence of metallo-\u03b2-lactamase acquired genes among carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR, Khartoum hospitals. Khartoum Sudan BMC Infect Dis. 2018;18:668.","journal-title":"Khartoum Sudan BMC Infect Dis"},{"key":"1053_CR32","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/cc9961","volume":"15","author":"P Montravers","year":"2011","unstructured":"Montravers P, Dupont H, Gauzit R, Veber B, Bedos JP, Lepape A. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care. 2011;15:R17.","journal-title":"Crit Care"},{"key":"1053_CR33","doi-asserted-by":"crossref","unstructured":"Goyal D, Dean N, Neill S, Jones P, Dascomb K. 2019. Risk Factors for Community-Acquired Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections-A Retrospective Study of Symptomatic Urinary Tract Infections. Open Forum Infect Dis 6:ofy357.","DOI":"10.1093\/ofid\/ofy357"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01053-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T21:23:09Z","timestamp":1642281789000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01053-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01053-7","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The appropriate ethical review boards of Arsi University, Ethiopia (reference number A\/U\/H\/S\/C\/120\/6443\/2017), the Oromia Regional Health Bureau, Ethiopia (reference number BEFO\/AHBTFH\/1-8\/2017), and D\u00fcsseldorf University Hospital, Germany (reference number 5729) approved the study. Ethical clearance for sample transportation between Ethiopia and Germany was obtained from the National Ethical Review Board of the Ethiopian Ministry of Science and Technology (reference number 310\/204\/2017). Before the start of the study procedures, written informed consent to participate in the study was obtained from each study participant or, in the case of minors, from their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent form signed by each study participant or, in the case of minors, the legal guardians contained consent for publication of anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}